Insider Transactions in Q2 2022 at Adma Biologics, Inc. (ADMA)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
May 11 2022	Adam S Grossman President and CEO	SELL Payment of exercise price or tax liability	Direct	70,004 -2.97%	$70,004 $1.43 P/Share
May 11 2022	Brian Lenz EVP, CFO	SELL Payment of exercise price or tax liability	Direct	51,965 -4.51%	$51,965 $1.43 P/Share

Receive a notification when an Institution or Guru buys or sells ADMA shares.

Notify only if

Value

Get notified when an Adma Biologics, Inc. insider buys or sells ADMA shares.

Notify only if

Operation

Value

Type

Receive news related to ADMA BIOLOGICS, INC.